2021 Annual Business Report

An established
vaccine company

img-small

CEO statement

“2021 was an exceptional year for Valneva”

Thomas Lingelbach President & CEO of Valneva

TOTAL
revenues 2021

348.1m
Our employees

Our employees

Valneva’s success stems from the dedication and expertise of over 750 employees spanning the whole value chain, from R&D to commercialization.

2021 Highlights

2021 Highlights

In 2021, Valneva achieved several major milestones, further enhancing its unique value proposition.

Our strategy

Our strategy

Valneva aims to become a highly valued, internationally known vaccine company focusing on products that can make a difference in people’s lives.

 

Citation-2021

Frédéric Jacotot General Counsel and Corporate Secretary

Our Corporate Governance Approach

Our Corporate Governance Approach

Our commitment to Corporate Governance underpins the trust that our investors, employees and institutions have placed in us.

Corporate Social Responsibility

Corporate Social Responsibility

Valneva has defined long-term responsible business commitments, which reflect global health needs and sit across four key focus areas. Our four pillars are the foundation for our Corporate Social Responsibility approach.